Question-and-Answer SessionSo perhaps we could start by having you give our audience a brief overview of Entrada Therapeutics and in particular, the Endosomal Escape Vehicles technology platform.Dipal DoshiCEO & Director Yes, happy to do that. So Entrada is a clinical stage biotech company that is aiming to transform patients' lives. We have a proprietary application or technology called Endosomal Escape Vehicles that we also call EEVs. We'll use that interchangeably, which we really believe enhances the va ...

Entrada Therapeutics (NasdaqGM:TRDA) Update / Briefing September 25, 2025 10:00 AM ET Company ParticipantsDipal Doshi - CEOConference Call ParticipantsRam Selvaraju - Managing Director and AnalystRam SelvarajuI'm joined by Dr. Salva Raggio. I'm a Managing Director and Senior Healthcare Equity Research Analyst here within the Equity Research Department at H.C. Wainwright & Company. I'm joined today by Dipal Doshi, Chief Executive Officer of Entrada Therapeutics. Entrada is traded on the Nasdaq under the tick ...